EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18 F-FDG-PET/CT images

Fanni Júlia Kiss, Anna Izabell Járó, Domokos Máthé, Csaba Benedek, Vilmos Madaras, Andrea Manno-Kovács, Árpád László Bartha, Parasuraman Padmanabhan, Ramasamy Paulmurugan, Eszter Regős, Tamás Györke, Krisztián Szigeti iD

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-025-07453-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Fanni Júlia Kiss und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Medical Imaging Centre, Faculty of Medicine, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Carcinoma, Non-Small-Cell Lung, Fluorodeoxyglucose F18, B7-H1 Antigen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Semmelweis University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Lung cancer is the most prevalent malignancy globally, with prognosis and treatment largely influenced by histological and molecular analyses. Molecular features like PD-L1 positivity help identify patients suitable for immunotherapy. However, obtaining histological samples can be challenging and limited. Radiomic analysis of imaging data provides a non-invasive way to characterize tumor heterogeneity and its complex patterns, which may help predict PD-L1 expression. This study investigates the efficacy of radiomics in forecasting PD-L1 status in NSCLC patients using 18 F-FDG-PET/CT images.

Methods

In this retrospective study, the primary staging 18 F-FDG-PET/CT scans of 105 patients with NSCLC of different phenotypes (72 ACC, 33 SCC, 64 PD-L1 positive, 41 PD-L1 negative) were analysed. Various segmentation techniques were employed. Radiomic features were obtained from the original and transformed images using the PyRadiomics package. Records were split into training and test sets in the ratio of 7:3. Feature reduction involved the Mann–Whitney U test, LASSO regression, and Spearman correlation analysis. A logistic regression model was developed using the selected features, and performance was assessed with ROC curve, AUC score, and other metrics.

Results

The optimal model achieved an AUC of 0.783 (95% CI: 0.625, 942), with high accuracy (81.25%), sensitivity (90.00%), PPV (81.81%), and NPV (80.00%).

Conclusion

Radiomic features derived from 18 F-FDG-PET/CT images can potentially differentiate between PD-L1 positive and negative NSCLC. Consequently, radiomics with multimodal imaging presents a promising non-invasive approach for selecting patients who may benefit from targeted immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyCarcinoma, Non-Small-Cell LungFluorodeoxyglucose F18B7-H1 AntigenLung NeoplasmsImage Processing, Computer-AssistedGene Expression Regulation, NeoplasticHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultAged, 80 and overRadiomics

Stichwörter der Autor:innen

18F-FDG-PET/CTComputed tomography (CT)Non-small cell lung cancerPD-L1Positron-emission tomography (PET)Radiomics

Substanzen

Fluorodeoxyglucose F18B7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Medical Imaging Centre, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Department of Biophysics and Radiation Biology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Institute of Nuclear Techniques, Budapest University of Technology and Economics, Budapest, Hungary.
  • In Vivo Imaging Advanced Core Facility, Hungarian Center of Excellence for Molecular Medicine (HCEMM), Budapest, Hungary.
  • HUN-REN Institute for Computer Science and Control (HUN-REN SZTAKI), Budapest, Hungary.
  • Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary.

ORCID-Profile: Krisztián Szigeti

Förderung

  • Semmelweis University

Zitieren

APA

Kiss, F. J., Járó, A. I., Máthé, D., Benedek, C., Madaras, V., Manno-Kovács, A., Bartha, Á. L., Padmanabhan, P., Paulmurugan, R., Regős, E., Györke, T., & Szigeti, K. (2026). Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18 F-FDG-PET/CT images. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07453-2

Vancouver

Kiss FJ, Járó AI, Máthé D, Benedek C, Madaras V, Manno-Kovács A, et al. Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18 F-FDG-PET/CT images. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07453-2

BibTeX
@article{Kiss2026,
  author = {Kiss, Fanni Júlia and Járó, Anna Izabell and Máthé, Domokos and Benedek, Csaba and Madaras, Vilmos and Manno-Kovács, Andrea and Bartha, Árpád László and Padmanabhan, Parasuraman and Paulmurugan, Ramasamy and Regős, Eszter and Györke, Tamás and Szigeti, Krisztián},
  title = {Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18 F-FDG-PET/CT images},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-025-07453-2}
}
Kostenlos starten →